Gene · 8242
Papers1,955
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,955
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. | F1000Res | 2023 | 38933491 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. | Front Immunol | 2023 | 38268926 | PubTator, text mining | PubMed |
| A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer. | J Gastrointest Oncol | 2023 | 38196539 | PubTator, text mining | PubMed |
| The role of gonadal hormones and sex chromosomes in sex-dependent effects of early nutrition on metabolic health. | Front Endocrinol (Lausanne) | 2023 | 38189044 | PubTator, text mining | PubMed |
| The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features. | Front Pharmacol | 2023 | 38178861 | PubTator, text mining | PubMed |
| Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 38136342 | PubTator, text mining | PubMed |
| Out of the Silence: Insights into How Genes Escape X-Chromosome Inactivation. | Epigenomes | 2023 | 38131901 | PubTator, text mining | PubMed |
| Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns. | Cancer Cell Int | 2023 | 38129839 | PubTator, text mining | PubMed |
Competing endogenous RNA network analysis of Turner syndrome patient-specific iPSC-derived cardiomyocytes reveals dysregulation of autosomal heart development genes by altered dosages of X-inactivation escaping non-coding RNAs. | Stem Cell Res Ther | 2023 | 38124119 | PubTator, text mining | PubMed |
| Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. | Res Sq | 2023 | 38106039 | PubTator, text mining | PubMed |
| Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort. | Nat Commun | 2023 | 38104198 | PubTator, text mining | PubMed |
| Epigenetic and Genetic Keys to Fight HPV-Related Cancers. | Cancers (Basel) | 2023 | 38067286 | PubTator, text mining | PubMed |
| Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories. | iScience | 2023 | 38034348 | PubTator, text mining | PubMed |
| Research progress of N6-methyladenosine in colorectal cancer: A review. | Medicine (Baltimore) | 2023 | 38013272 | PubTator, text mining | PubMed |
| Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. | Genome Biol | 2023 | 38012744 | PubTator, text mining | PubMed |
| Muscle miRNAs are influenced by sex at baseline and in response to exercise. | BMC Biol | 2023 | 38012706 | PubTator, text mining | PubMed |
| Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis. | Viruses | 2023 | 38005929 | PubTator, text mining | PubMed |
| Entecavir: A Review and Considerations for Its Application in Oncology. | Pharmaceuticals (Basel) | 2023 | 38004468 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 38003482 | PubTator, text mining | PubMed |
| Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37981648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8242/papers?page=8